ENO

One with heart.

Healthcare Professionals Cardiac Rhythm Management Pacemakers ENO

World’s smallest transvenous pacemaker.1

1.5 T and 3 T full body MR conditional.

Empower AF Risk Management.
Minimize ventricular pacing for SND and AVB patients.
Screen and Monitor for Sleep Apnea.

ENO DR Micro Port 2018

SafeR™

Dramatically reduces unnecessary RV pacing in all pacemaker patients, including AV block patients.

Discover this therapy

SAM™

Sleep Apnea Monitoring measures respiration pauses and reduction in respiration.

Discover this therapy

AutoMRI™

Making MRI scans easy and safe for pacemaker patients.

Discover this feature

Dual Sensor™

Designed to physiologically modulate heart rhythm by combining Accelerometer and Minute Ventilation sensors.

Discover this therapy

AF risk management

Helping you manage what can't be seen

Ventricular Pacing reduction: Protect patients from developing AF2,3,4

Atrial prematurity detection: Detect AF with 96% sensitivity and 96% specificity5

Sleep Apnea screening: Reveal the silent cause of AF6,7

Control AF recurrence risk: Long-term sleep apnea monitoring helps prevent resurgence of AF 8,9,10

CRM Helpingyoumanage 1

φ Intelligence

Physio-inspired design

Mimics the natural way the heart works and minimizes artificial intervention.

Wave to wave thinking

Permanent adaptive strategy for real time decisions that respond to all levels of patient activity, day and night, evolving and learning with the patient.

Symbiotic programming

Programming is driven only by hemodynamic needs. All therapeutic features are independently programmable, designed to work simultaneously together with no conflict.

CRM Intelligence

Ratio Design

8 cc

  • Smaller incision & reduced pocket size
  • Boosts psychological adoption for patients

Ellipse Shape

  • Natural lead wrap around
  • Facilitates insertion and lead connection

12 years longevity* in 8 cc

  • Avoid complications due to risky replacement procedures11,12

Best longevity per cc

  • MicroPort CRM’s technology brings together size and longevity.
  • 12 years longevity* in 8 cc.

AutoMRI


Visit. Scan. Go.

Automatic switch in and out of MRI mode upon detection of MR field.
No need to accompany the patient during or after the scan.
Multiple MRI scans possible during the programmed window.
No post MRI follow-up.

Ease the workflow.

  1. Patient visits the cardiologist
  2. 10 day window where the patient can have an MRI scan.
  3. Patient enters MRI scan.
  4. Patient can go home.

AutoMRI comes as standard
2014 Innovation award.
Longest experience in automatic MRI detection.

CRM Cardiostim innovation Awards

Availability of select products and their functions varies by country. Please check with your representative for further information.

Related products:
Orchestra Plus programmer; Leads; Vega; Xfine

*SafeR Mode (5% V pacing, 50% A pacing), 60 min-1, 2.5 V, 0.4 ms, 750 Ω, SENSORS ON, EGMs ON.


REFERENCES

  1. Competition comparison across transvenous pacing systems made as of October 2018, refer to manufacturers manuals.
  2. Thibault B, Ducharme A, Baranchuk A, et al. Very Low Ventricular Pacing Rates Can Be Achieved Safely in a Heterogeneous Pacemaker Population and Provide Clinical Benefits: The CANadian Multi-Centre Randomised Study – Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVER) Trial. J Am Heart Assoc. 23:4(7), 2015.
  3. Boveda S, Defaye P, Moreno J et al. Minimized ventricular pacing to prevent the first onset of AF in pacemaker patients without atrial arrhythmia history: results from the ANSWER study, Europace Abstracts 17(Suppl3):iii24, 2015.
  4. Fauchier L, Moreno J, Defaye P, Stockburger M. SafeR is associated with a risk reduction of first-onset AF” et “Europace 8(suppl 1): i170, 2016.
  5. Géroux L, Limousin M, Cazeau S. Clinical performances of a new mode switch function based on a statistical analysis of the atrial rhythm. HerzschrElektrophys10: Suppl1I/15 – I/21 SteinkopffVerlag, 1999.
  6. Mehra R et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir CritCare Med Vol173:910–916, 2006.
  7. Defaye P, De la Cruz L, Martí-Almor J et al. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe sleep apnea: The DREAM European study. Heart Rhythm; 11:842-848, 2014.
  8. Monahan K, Brewster J, Wang L et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012 August 1; 110(3): 369–372.
  9. Kanagala R et al. – Obstructive Sleep Apnea and the recurrence of Atrial Fibrillation. Circulation 2003
  10. Fein S A, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. JACC 2013; 62 (4).
  11. Stockburger M, Defaye P, Boveda S et al. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular-block: impact on battery longevity-a substudy of the ANSWER trial. Europace; 18:739–746, 2.
  12. Polyzos KA. et al. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace ; 17 :167-777,2015.